1Takara K,Sakaeda T,Okumura K.An update on overcomingMDR1-mediated multidrug resistance in cancer chemotherapy[J].Curr Pharm Des,2006,12(3):273.
2Riou GF,Zhou D,Ahomadegbe JC,et al.Expression of multidrug-resistance (MDR1) gene in normal epithelia and in invasive carcinomas of the uterine cervix[J].J Natl Cancer Inst,1990,82(18):1493.
4Konishi I,Nanbu K,Mandai M,et al.Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma[J].Gynecol Oncol,1998,70(3):365.
7de Camargo JL,Tsuda H,Tatematsu M,et al.Placental form of glutathione S-transferase in normal and diseased human uterine cervical mucosa[J].Carcinogenesis,1989,10(12):2317.
10Drake FH,Zimmerman JP,McCabe FL,et al.Purification of topoisomerase Ⅱ from amsacrine-resistant P388 leukemia cells.Evidence for two forms of the enzyme[J].J Biol Chem,1987,262(34):16739.
4[1]Takebayashi Y, Nakayama K, Fujioka T, et al. Expression of multidrug resistance associated transporters (MDR1,MRP1,LRP and BCRP) in porcine oocyte [J]. Int J Mol Med, 2001, 7(4):397-400.
5[2]Chung HC, Rha SY, Kim JH, et al. P-glyccoprotein:the intermediate end point of drug response toinduction chemotherapy in locally advanced breast cancer[J]. Breast Cancer Res Treat, 1997, 42(1):65-72.
6[3]Lee WP, Lee CL, Lin HC, et al. Glutathione S-transferase and glutathione periodase are essential in the early stage of adriamycin resistance before p-glycoprotein in overexpression in HOB1 lymphoma cells[J]. Cancer Chemother Pharmacol, 1996,38(1 ):45 -51.
7[4]Wei YQ, Zhao X, Kariya Y, et al. Inhibition of proliferation and induction of apoptosis by abrogation of heat shock protein (HSP) 70 expression in tumor cells[J]. Cancer Immunol Immunother, 1995,40(2):73.
8[5]Lazaris Ach, Chatzigianni EB, Panoussopoulos D, et al.Prolifetating cell nuclear antigen and heat shock protein 70 immunolocolization in invasive ductal breast cancer not otherwise specified[J]. Breast Res Treat, 1997, 43(1):43.
9Riou G F，J Natl Cancer Ins，1990年，82卷，18期，1493页
10Huang LW,Chao SL,Chen PH,et al.Multiple HPV genotypes in cervical carcinomas:improved DNA detection and typing in archival tissues[J].J Clin Virol,2004,29:271-276
1Hemaiswarya S,Doble M.Combination of phenylpropanoids with 5-fluorouracil as anti-cancer agents against human cervical cancer(HeLa)cell line[J].Phytomedicine,2013,20(2):151-158.
2Gravells P,Hoh L,Canovas D,et al.Resistance of uveal melanoma to the interstrand cross-linking agent mitomycin C is associated with reduced expression of CYP450R[J].Br J Cancer,2011,29,104(7):1 098-1 105.
3Mayur YC,Peters GJ,Prasad VV,el al.Design of new drug molecules to be used in reversing multidrug resistance in cancer cells[J].Curr Cancer Drug Targets,2009,9(3):298-306.
4Rafael J,Angelica LF,Aaron A,et al.Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma:An in vitro and in vivo study[J].Oncology Reports,2009,22(5):1 237-1 245.
5Kontzoglou K,Palla V,Karaolanis G,et al.Correlation between Ki67and breast cancer prognosis[J].Oncology,2013,84(4):219-225.
